Singapore's BIOBOT Surgical raises $15.4 million to expand US operations, advance robotic prostate cancer diagnosis, and strengthen global healthcare growth.
Journals
Editor's Guest
Ensuring Excellent Mobile Connectivity for...
Technology in Cancer Care: A story of evolving...
Bringing Shop Floor to Manufacturer's palm:...
As global competition intensifies, Samsung is investing in talent, acquisitions, and infrastructure to stay ahead
Asia’s business landscape gains momentum as fintech, robotics, wealthtech and manufacturing investments expand across India,…
Singapore startup K25 AI secures $2M from a Nasdaq-listed firm to expand enterprise AI solutions, boost growth, and strengthen…
Asia's business landscape gains momentum with new deals in digital payments, cybersecurity, defence, space and electric mobility…
DBS becomes the first Singapore-listed company to surpass S$200 billion in market value, driven by strong earnings, digital…
Singapore’s Sharpa powers the H2 humanoid robot with advanced robotic hand technology, strengthening its role in the global AI…
